Timothy F Cloughesy Selected Research

Peptides (Polypeptides)

2/2013	Comparison of glioma-associated antigen peptide-loaded versus autologous tumor lysate-loaded dendritic cell vaccination in malignant glioma patients.
12/2008	Randomized phase II study of cilengitide, an integrin-targeting arginine-glycine-aspartic acid peptide, in recurrent glioblastoma multiforme.
8/2005	Dendritic cell vaccination in glioblastoma patients induces systemic and intracranial T-cell responses modulated by the local central nervous system tumor microenvironment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Timothy F Cloughesy Research Topics

Disease

152	Neoplasms (Cancer) 05/2024 - 09/2002
137	Glioblastoma (Glioblastoma Multiforme) 11/2023 - 09/2002
98	Glioma (Gliomas) 05/2024 - 04/2002
49	Brain Neoplasms (Brain Tumor) 10/2023 - 01/2004
4	Hypoxia (Hypoxemia) 01/2022 - 05/2007
3	Astrocytoma (Pilocytic Astrocytoma) 01/2024 - 03/2014
3	Diarrhea 01/2018 - 01/2004
3	Edema (Dropsy) 01/2012 - 05/2007
3	Meningioma (Meningiomas) 01/2010 - 12/2009
2	Disease Progression 05/2024 - 08/2023
2	Lymphoma (Lymphomas) 01/2023 - 11/2004
2	Oligodendroglioma 01/2021 - 10/2008
2	Hypertension (High Blood Pressure) 01/2020 - 01/2018
2	Fatigue 01/2019 - 01/2018
2	Residual Neoplasm 01/2019 - 01/2018

Drug/Important Bio-Agent (IBA)

28	Bevacizumab (Avastin)FDA Link 01/2021 - 06/2008
25	Biomarkers (Surrogate Marker)IBA 01/2024 - 08/2008
24	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2024 - 03/2012
24	Temozolomide (Temodar)FDA LinkGeneric 01/2024 - 02/2007
22	ErbB Receptors (EGF Receptor)IBA 12/2022 - 09/2002
14	EnzymesIBA 01/2024 - 01/2004
13	DNA (Deoxyribonucleic Acid)IBA 01/2024 - 10/2004
13	Proteins (Proteins, Gene)FDA Link 01/2022 - 07/2005
13	Phosphotransferases (Kinase)IBA 01/2020 - 06/2003
13	epidermal growth factor receptor VIIIIBA 07/2015 - 09/2002
11	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2023 - 05/2007
10	MethyltransferasesIBA 01/2024 - 01/2012
10	Erlotinib Hydrochloride (CP 358,774)FDA Link 10/2020 - 11/2005
8	AminesIBA 08/2023 - 11/2015
7	fluorodopa F 18IBA 05/2021 - 08/2012
7	VaccinesIBA 10/2020 - 08/2005
7	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2019 - 07/2005
6	Messenger RNA (mRNA)IBA 03/2024 - 07/2005
6	Protons (Proton)IBA 06/2023 - 03/2012
6	Amino Acids FDA Link 01/2023 - 05/2014
6	Tyrosine Kinase InhibitorsIBA 10/2020 - 10/2010
6	Mechanistic Target of Rapamycin Complex 2IBA 12/2019 - 11/2011
6	Irinotecan (Camptosar)FDA LinkGeneric 01/2018 - 04/2002
6	TOR Serine-Threonine KinasesIBA 09/2015 - 08/2006
6	Sirolimus (Rapamycin)FDA Link 04/2014 - 08/2006
6	Anticonvulsants (Antiepileptic Drugs)IBA 10/2010 - 01/2004
5	CholesterolIBA 01/2023 - 08/2009
5	Oxygen (Dioxygen)IBA 05/2022 - 11/2018
5	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2013
5	Adenosine Triphosphate (ATP)IBA 11/2015 - 12/2004
4	alpha-hydroxyglutarateIBA 03/2024 - 03/2012
4	RNA (Ribonucleic Acid)IBA 03/2024 - 01/2015
4	Angiogenesis InhibitorsIBA 11/2023 - 04/2010
4	vorasidenibIBA 08/2023 - 01/2021
4	ivosidenibIBA 07/2023 - 10/2020
4	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2021
4	Phenylalanine (L-Phenylalanine)FDA Link 09/2021 - 07/2014
4	Lapatinib (GW572016)FDA Link 10/2020 - 12/2009
4	Growth Factor ReceptorsIBA 12/2019 - 07/2015
4	LigandsIBA 01/2019 - 09/2002
4	tipifarnib (R115777)IBA 01/2018 - 09/2005
4	cabozantinibIBA 01/2018 - 01/2017
3	vocimagene amiretrorepvecIBA 12/2020 - 01/2016
3	Fatty Acids (Saturated Fatty Acids)IBA 10/2020 - 08/2009
3	Sorafenib (BAY 43-9006)FDA Link 01/2020 - 12/2012
3	Lipase (Acid Lipase)FDA Link 01/2020 - 01/2018
3	LipidsIBA 01/2019 - 08/2010
3	Angiopoietin-2IBA 03/2018 - 05/2007
3	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2018 - 12/2012
3	Monoclonal AntibodiesIBA 01/2017 - 09/2009
3	Phosphatidylinositols (Phosphatidylinositol)IBA 09/2015 - 06/2003
3	temsirolimus FDA Link 04/2014 - 12/2007
3	Peptides (Polypeptides)IBA 02/2013 - 08/2005
2	resiquimodIBA 05/2024 - 09/2023
2	poly ICLCIBA 05/2024 - 09/2023
2	InterferonsIBA 05/2024 - 01/2019
2	Toll-Like Receptor AgonistsIBA 05/2024 - 09/2023
2	TIC10 compoundIBA 11/2023 - 01/2021
2	pembrolizumabIBA 06/2023 - 01/2019
2	SolutionsIBA 10/2022 - 10/2011
2	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 01/2022 - 01/2021
2	HexokinaseIBA 01/2022 - 01/2021
2	Atorvastatin (Lipitor)FDA Link 01/2021 - 12/2009
2	Dopamine AntagonistsIBA 01/2021 - 01/2020
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2021 - 01/2020
2	Flucytosine (Ancobon)FDA Link 12/2020 - 01/2016
2	tyrosine receptor (receptor, tyrosine)IBA 01/2020 - 04/2010
2	Epidermal Growth Factor (EGF)IBA 01/2020 - 12/2004
2	GDC-0084IBA 01/2020 - 01/2020
2	Oxidoreductases (Dehydrogenase)IBA 12/2019 - 12/2009
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2019 - 11/2011
2	MicroRNAs (MicroRNA)IBA 01/2018 - 11/2014
2	Alanine Transaminase (SGPT)IBA 01/2018 - 08/2006
2	Glutamic Acid (Glutamate)FDA Link 07/2017 - 12/2012
2	pexidartinibIBA 01/2017 - 04/2016
2	Macrophage Colony-Stimulating FactorIBA 01/2017 - 04/2016
2	ParaffinIBA 01/2017 - 07/2013
2	afliberceptIBA 01/2017 - 07/2011

Therapy/Procedure

89	Therapeutics 12/2023 - 09/2002
18	Radiotherapy 11/2023 - 03/2004
14	Drug Therapy (Chemotherapy) 01/2023 - 05/2003
8	Immunotherapy 10/2023 - 02/2013
7	Chemoradiotherapy 11/2015 - 04/2010
6	Aftercare (After-Treatment) 01/2023 - 11/2014
2	Investigational Therapies (Experimental Therapy) 01/2022 - 11/2004